Animal disease model construction, drug administration, sampling, and in vivo efficacy evaluation – a complete workflow

Select or establish appropriate animal models based on clear scientific questions, and complete study design, randomization, drug administration, observation, sample collection, endpoint evaluation, and traceable data quality control.

Experimental Objective

To select or establish appropriate animal models based on clear scientific questions, and complete study design, randomization, drug administration, observation, sample collection, endpoint evaluation, and traceable data quality control.

Scope of Application and Experimental Requirements

  • Samples: Experimental animals approved by ethics committee
  • Samples: Standardized cells, tissues, or modeling materials
  • Samples: Candidate drugs, antibodies, or other research interventions
  • Samples: Blood, tissues, and other endpoint samples
  • Species: Mice, rats, and other model species scientifically validated and ethically approved
  • Difficulty and Duration: Advanced, approximately 2–16 weeks, depending on the model and endpoint
  • Safety: Research must obtain institutional animal ethics approval and adhere to the 3Rs principles, personnel qualifications, facility permits, animal welfare, and humane endpoints; models involving infection, tumors, genetic modifications, or hazardous compounds require additional risk assessment.

Experimental Principle

To reproduce target diseases or physiological characteristics through genetic background, transplantation, induction, infection, or other approved modeling methods, and evaluate the in vivo effects and safety signals of candidate interventions under pre-defined controls, endpoints, and statistical plans.

Standard Workflow

  1. Clearly define research hypotheses, primary endpoints, effect sizes, and ethical boundaries
  2. Select models, species, strains, genders, ages, and inclusion/exclusion criteria
  3. Complete sample size planning, randomization, grouping, and blinding protocols
  4. Establish models according to the approved protocol and confirm baseline consistency
  5. Perform standardized drug administration, observation, and animal welfare monitoring
  6. Collect in vivo readouts and blood/tissue samples according to the timeline
  7. Complete efficacy, safety signals, and endpoint analysis based on pre-defined criteria
  8. Lock data, record deviations, and complete statistical and reproducibility reviews

Equipment, Reagents, and Consumables

  • Equipment: Compliant animal facilities and environmental monitoring systems, weight, behavior or physiological monitoring equipment, drug administration, imaging or sampling equipment, sample processing, storage, and endpoint analysis platforms
  • Reagents: Confirmed modeling materials and research interventions, anesthesia, analgesia, and supportive materials (according to approved protocol), biomarkers, histological and pharmacokinetic detection systems, positive controls, and vehicle controls
  • Consumables: Animal identification and record-keeping supplies, compliant drug administration and sampling consumables, sample collection, transport, and cryopreservation consumables, personal protective equipment, and waste management supplies

Required Controls and QC

  • Healthy or sham-operated controls
  • Model vehicle controls
  • Known positive interventions
  • Randomization and blinding assessment
  • Pre-defined exclusion criteria and batch reference samples
  • Completeness of ethics and protocol documents; traceability of animal identity, grouping, and drug administration records; controlled model success rate and baseline differences; correct direction of positive controls; primary endpoints analyzed according to blinding and pre-defined statistical plan; complete records of deviations and exclusions.

Key Parameters and Result Interpretation

Model adaptability, genetic background, gender and age, environment, randomization, sample size, drug exposure, operator effect, primary endpoints, humane endpoints, and handling of missing data determine the quality of conclusions.

Animal models only simulate part of the disease characteristics, and in vivo efficacy cannot be directly equated with clinical effects. Conclusions should consider model limitations, exposure, gender, and batch effects, and be validated through independent replication, in vitro mechanisms, and translational biomarkers.

Common Problems and Troubleshooting

When model variability is high, verify consistency of animal background, modeling materials, and operators; when controls are abnormal, pause interpretation and check for batch and environmental issues; when exposure is insufficient, evaluate formulation and pharmacokinetics; when endpoint noise is high, strengthen blinding, standardization, and pre-definition; when welfare indicators are abnormal, immediately execute approved humane disposal procedures.

Product BOM Entry

Submit Product and Technical Inquiry for This Experiment

Note for Scientific Research Use: This workflow is for scientific experimental design and product selection only; specific parameters, compatibility, specifications, prices, and delivery are subject to project evaluation and formal quotation.